Ken Griffin's position in Novo Nordisk - ADR is currently worth $145 Million. That's 0.15% of their equity portfolio (153rd largest holding). The first Novo Nordisk - ADR trade was made in Q3 2014. Since then Ken Griffin bought shares 50 more times and sold shares on 44 occasions. The stake costed the investor $109 Million, netting the investor a gain of 33% so far.